81
Views
40
CrossRef citations to date
0
Altmetric
Research Article

Anti-Soluble Liver Antigen/Liver-Pancreas (SLA/LP) Antibodies in Pediatric Patients with Autoimmune Hepatitis

, , &
Pages 485-492 | Published online: 07 Jul 2009

  • Czaja, A.J. (1998) "Treatment of autoimmune hepatitis". In: Krawitt. E.L. Wiesner. R.H. and Nishioka, M. eds. Autoimmune Liver Diseases. 2nd Ed. (Elsevier. Amsterdam), pp 499-515.
  • Johnson, P.J. and McFarlane, I.G. (1993) "Meeting report: International Autoimmune Hepatitis Group". Hepatolgy 18, 998-1005.
  • Alvarez, F. Berg, P.A. Bianchi, F.B. Manns, M.P. McFarlane, I.G. Meyer zum Buschenfelde, K.H. el al. (1999) "International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis". J. Hepatol. 31, 929-938.
  • Homberg, J.C. Abuaf, N. Bernard, O. Islam, S. Alvarez, F. Khalil, S.H. el al. (1987) "Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis". Hepatology 7, 1333-1339.
  • Czaja, A.J. (1999) "Behaviour and significance of autoantibodies in type 1 autoimmune hepatitis", J Hepatol. 30, 394-401.
  • Czaja, A.J. and Manns, M.P. (1995) "The validity and importance of subtypes in autoimmune hepatitis: a point of view". Am. J. Gastroenterol 90, 1206-1211.
  • Lapierre, P. Hajoui, O. Homberg, J.C. and Alvarez, F. (1999) "Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis". Gastroenterology 116, 643-649.
  • Manns, M. Gerkuen, G. and Kyriatsoulis, A. (1987) "Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen". Lancet 32, 635-640.
  • Stechemesser, E. Klein, R. and Berg, P.A. (1993) "Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis". Hepatology 18, 1-9.
  • Wies. I., Brunner, S. Henninger, J. Herkel, J. Kanzler, S. Meyer zum Buschenfelde, K.H. er al. (2000) "Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis", Lancet 355, 1510-1515.
  • Costa, M. Rodriguez-Sanchez, J.L. Czaja, A.J. and Gelpi, C. (2000) "Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis". Clin. Exp. Immunol. 121, 364-374.
  • Wachter, B. Kyriatsoulis, A. Lohse, A.W. Gerken, G. Meyer zum Buschenfelde, K.H. and Manns, M. (1990) "Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies". J. Hepatol. 11, 232-239.
  • Wesierska-Gadek, J. Grimm, R. Hitchman, E. and Penner, E. (1998) "Members of the glutathione 5-transferase gene family are antigens in autoimmune hepatitis". Gastroenterology 114, 329-335.
  • Czaja, A.J. Carpenter, H.A. and Manns, M.P. (1999) "Antibodies to soluble liver antigen. P450IID6. and mitochondrial complexes in chronic hepatitis". Gastroenterology 105, 1522-1528.
  • Kanzler, S. Weidemann, C. Gerken, G. Lohr, H.F. Galle, P.R. Meyer zum Buschenfelde, K.H. et al. (1999) "Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis". J. Hepatol. 31, 635-640.
  • Baeres, M. Herkel, J. Czaja, A.J. Wies, I. Kanzler, S. Cancado, E.L. er dl. (2002) "Establishment of standardized SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics", Gut 51, 259-264.
  • Czaja, A.J. Donaldson, PT. and Lohse, A.W. (2002) "Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis". Am. J. Gtistroenterol. 97, 413-419.
  • Amar-Costesec, A. Beaufay, H. Wibo, M. Thines-Sempoux, D. Feytmans, E. Robbi. M. et al. (1974) "Analytical study of microsomes and isolated subcellular membranes from rat liver. II. Preparation and composition of the microsomal fraction". J. Cull. Biol, 61, 201-212.
  • Vitozzi, S. Lapierre, P. Djilali-Saiah, I. and Alvarez, F. (2002) "Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant fusion protein". J. Immunolol. Methods 262, 103-110.
  • Margulies, D.H. (1995) "Molecular biology". In: Coligan, J.E. Kruisbeek, A.M. Margulies, D.H. Shevach, E.M. and Strober, W. eds. Current Protocol in Immunology (John Wiley & Sons, New York) Vol. 2. pp 101101-101111.
  • Coligan, J.E. (1999) "Protein". In: Coligan, J.E. Kruisbeek, A.M. Margulies, D.H. Shevach, E.M. and Strober, W. eds. Current Protocol in Immunology (John Wiley & Sons, New York) Vol. 2. pp 831-839.
  • Towbin, H. Staehelin, T. and Gordon, J. (1979) "Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets". Proc. Natl Acad. Sci. USA 76, 4350-4354.
  • Ma, Y. Okamoto, M. Thomas, M.G. Bogdanos, D.P. Lopes, A.R. Portmann, B. et al. (2002) "Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease". Hepatolony 35, 658-664.
  • Herkel, J. Heidrich, B. Nieraad, N. Wies, I. Rother, M. and Lohse, A.W. (2002) "Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas". Heptitology 35, 403-408.
  • Czaja, A.J. Carpenter, H.A. and Manns, M.P. (1999) "Antibodies to soluble liver antigen in autoimmune hepatitis", J Hepalol, 31. 63S-640.
  • Ballot, E. Homberg, J.C. and Johanet, C. (2000) "Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis", J Hepatol. 33, 208-215.
  • Peakman, M. Lobo-Yeo, A. Mieli-Vergani, G. Davies, E.T. Mowat, A.P. and Vergani, D. (1987) "Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidences for IgG1 subclasses restriction. policlonality and non-cross reactivity with hepatocyte surfaces antigen". Clin. Exp. Immunol. 69, 543-549.
  • Maran, R. Dueymes, M. Le Corre, R. Renaudineau, Y. Shoenfeld. Y and Youinou, P (1997) "IgG subclasses of human autoantibodies". Ann. Med. Intent. 148, 29-38.
  • Muratori, L. Cataleta, M. Muratori, P. Lenzi, M. and Bianchi, F.B. (1998) "Liver kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis", Gur 42, 721-726.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.